Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination
File(s)
Author(s)
Type
Journal Article
Abstract
Vaccines for COVID-19were developed with unprecedented speedand since January 2021, the AstraZeneca/Oxford University ChAdOx1 nCoV-19 vaccine has been administered to over 400 million people globally1. In April 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA)reported a possible association between ChAdOx1 nCoV-19 and a rare syndrome of unusual site thrombosis combined with thrombocytopenia, termed vaccine-induced immune thrombotic thrombocytopenia (VITT).Frequency of VITT varies across age groups. Overall 411 cases of VITT have been reported to Medicine & Healthcare prodcuts Regulatory Agency (MHRA) by 21st of July 2021 with fatality rate of 17.76% (73/411)2.
Date Issued
2022-03-14
Date Acceptance
2021-08-26
Citation
Journal of Neurology, Neurosurgery and Psychiatry, 2022, 93 (4), pp.445-448
ISSN
0022-3050
Publisher
BMJ Publishing Group
Start Page
445
End Page
448
Journal / Book Title
Journal of Neurology, Neurosurgery and Psychiatry
Volume
93
Issue
4
Copyright Statement
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. This article has been accepted for publication in Journal of Neurology, Neurosurgery & Psychiatry following peer review. The definitive copyedited, typeset version Crossette-Thambiah C, Pericleous C, Asmar N, et alClinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccinationJournal of Neurology, Neurosurgery & Psychiatry 2022;93:445-448 is available online at: http://dx.doi.org/10.1136/jnnp-2021-327340
This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. This article has been accepted for publication in Journal of Neurology, Neurosurgery & Psychiatry following peer review. The definitive copyedited, typeset version Crossette-Thambiah C, Pericleous C, Asmar N, et alClinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccinationJournal of Neurology, Neurosurgery & Psychiatry 2022;93:445-448 is available online at: http://dx.doi.org/10.1136/jnnp-2021-327340
Identifier
https://jnnp.bmj.com/content/93/4/445
Subjects
Science & Technology
Life Sciences & Biomedicine
Clinical Neurology
Psychiatry
Surgery
Neurosciences & Neurology
COVID-19
sinus thrombosis
COVID-19
sinus thrombosis
Neurology & Neurosurgery
11 Medical and Health Sciences
17 Psychology and Cognitive Sciences
Publication Status
Published
Date Publish Online
2021-09-29